BRL-305

N/A

Report date: 2024/04/25 10:31:32

Base Information

Drug NameBRL-305
Drug Alias NameBRL-305
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionB-cell maturation protein modulators
TargetsB-cell maturation protein
Therapy Area/IndicationsStomach NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBRL Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesBRL Medicine Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A